Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".
作者信息
Hadziyannis Stephanos J
机构信息
Department of Medicine and Hepatology, Henry Dunant Hospital, 107 Messogion Ave., Athens, 115 26, Greece,
出版信息
Hepatol Int. 2007 Jun;1(2):281-4. doi: 10.1007/s12072-007-9004-7.
Abstract
摘要
相似文献
1
Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".
Hepatol Int. 2007 Jun;1(2):281-4. doi: 10.1007/s12072-007-9004-7.
2
Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
J Clin Virol. 2014 Apr;59(4):228-34. doi: 10.1016/j.jcv.2014.01.013. Epub 2014 Jan 26.
3
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1481-1489.e5. doi: 10.1016/j.cgh.2016.01.019. Epub 2016 Feb 10.
4
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
Clin Microbiol Infect. 2017 Nov;23(11):860-867. doi: 10.1016/j.cmi.2017.03.003. Epub 2017 Mar 11.
5
Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
Liver Int. 2017 Nov;37(11):1622-1631. doi: 10.1111/liv.13416. Epub 2017 Apr 18.
6
[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Mikrobiyol Bul. 2007 Jan;41(1):87-93.
7
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.
8
Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
Diagn Microbiol Infect Dis. 2015 Jun;82(2):114-9. doi: 10.1016/j.diagmicrobio.2015.02.005. Epub 2015 Feb 20.
9
Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
J Clin Gastroenterol. 2014 Feb;48(2):166-71. doi: 10.1097/MCG.0b013e3182a4711d.
10
Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.
Liver Int. 2015 Jan;35(1):130-9. doi: 10.1111/liv.12661. Epub 2014 Sep 15.
引用本文的文献
1
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase.
World J Hepatol. 2024 Jun 27;16(6):920-931. doi: 10.4254/wjh.v16.i6.920.
2
The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis.
Front Cell Infect Microbiol. 2023 Sep 12;13:1226755. doi: 10.3389/fcimb.2023.1226755. eCollection 2023.
3
Definition and classification of acute-on-chronic liver diseases.
World J Clin Cases. 2022 May 26;10(15):4717-4725. doi: 10.12998/wjcc.v10.i15.4717.
4
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection.
J Clin Med. 2019 Dec 2;8(12):2101. doi: 10.3390/jcm8122101.
5
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.
World J Gastroenterol. 2014 Jun 28;20(24):7644-52. doi: 10.3748/wjg.v20.i24.7644.
本文引用的文献
1
Spontaneous relapse of hepatitis in inactive HBsAg carriers.
Hepatol Int. 2007 Jun;1(2):311-5. doi: 10.1007/s12072-007-9002-9.
2
Chronic hepatitis B.
Hepatology. 2007 Feb;45(2):507-39. doi: 10.1002/hep.21513.
3
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
Clin Gastroenterol Hepatol. 2006 Aug;4(8):936-62. doi: 10.1016/j.cgh.2006.05.016. Epub 2006 Jul 14.
4
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
Clin Gastroenterol Hepatol. 2006 Feb;4(2):233-48. doi: 10.1016/s1542-3565(05)00983-3.
5
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.
Liver Int. 2005 Jun;25(3):472-89. doi: 10.1111/j.1478-3231.2005.01134.x.
6
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.
Gastroenterology. 2004 Sep;127(3):756-63. doi: 10.1053/j.gastro.2004.06.021.
7
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Am J Med. 2004 Jun 15;116(12):829-34. doi: 10.1016/j.amjmed.2003.12.040.
8
Chronic hepatitis B: update of recommendations.
Hepatology. 2004 Mar;39(3):857-61. doi: 10.1002/hep.20110.
9
Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
Am J Gastroenterol. 2003 Oct;98(10):2261-7. doi: 10.1111/j.1572-0241.2003.07715.x.
10
A "NEW" ANTIGEN IN LEUKEMIA SERA.
JAMA. 1965 Feb 15;191:541-6. doi: 10.1001/jama.1965.03080070025007.
Zotero 插件